Matthias Frech

Title: Matthias Frech: Innovator in Medical Technology

Introduction

Matthias Frech is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of medical technology, particularly in the area of thrombosis and vascular injuries. With a total of two patents to his name, Frech's work focuses on innovative solutions that enhance patient care and treatment outcomes.

Latest Patents

Frech's latest patents include a specific mechanism for inhibiting platelet adhesion to collagen. This invention relates to the polypeptide Saratin and its use in manufacturing a medicament capable of significantly decreasing platelet adhesion and accumulation after vascular injuries or endarterectomy. Furthermore, the invention highlights a novel medical use of Saratin as an inhibitor of thrombosis and intimal hyperplasia. The Saratin polypeptide can be utilized locally as a topical agent or as a coating on medical devices or vascular grafts. Another patent focuses on the use of Saratin for inhibiting platelet adhesion to collagen, emphasizing its potential in the medical field.

Career Highlights

Throughout his career, Matthias Frech has worked with prominent companies such as Merck GmbH and Merck Patent GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Frech has collaborated with notable professionals in his field, including Christopher Barnes and Uwe Hofmann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Matthias Frech is a distinguished inventor whose work in medical technology has the potential to significantly impact patient care. His innovative patents and collaborations reflect his commitment to advancing the field and improving treatment options for vascular injuries.